A 2021 meta-analysis of 14 case–control and cohort studies (total ≈ 6800) reported that elevated circulating leptin was associated with a pooled relative risk for AD of 0.68 (95% CI: 0.54–0.85), with more potent effects in prospective versus cross-sectional designs [294]. Here, LEP is linked to Alzheimer disease.